Atrium Therapeutics Inc (RNA)
Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 18,755 | 10,897 | 9,560 | 9,224 | 9,326 |
| Gross Profit | 18,755 | 10,897 | 9,560 | 9,224 | 9,326 |
| Operating Expenses | 205,539 | 86,240 | 54,190 | 37,733 | 26,195 |
| Operating Income | -186,784 | -75,343 | -44,630 | -28,509 | -16,869 |
| Other Income | -497,847 | -246,959 | -167,590 | -145,486 | -101,140 |
| Pre-tax Income | -684,631 | -322,302 | -212,220 | -173,995 | -118,009 |
| Net Income Continuous | -684,631 | -322,302 | -212,220 | -173,995 | -118,009 |
| Net Income | $-684,631 | $-322,302 | $-212,220 | $-173,995 | $-118,009 |
| EBITDA(a) | $-186,784 | $-75,343 | $-44,630 | $-28,509 | $-16,869 |